Skip to main content

Advertisement

SpringerLink
Log in

Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Nonalcoholic fatty liver disease incidence is related to the presence of obesity and insulin resistance. A treatment of this disease in patients with morbid obesity is bariatric surgery and its diagnosis is extremely important due to the possible progression to cirrhosis or hepatocellular carcinoma. The development of clinical-laboratorial analysis tools to this disease and its complications is necessary as the gold standard for its diagnosis is an invasive procedure. The objective of the study is to evaluate the use of BARD score in the selection of patients who should undergo liver biopsy during bariatric surgery.

Methods

It was a retrospective analysis of patients with hepatic disease who were biopsied between 2012 and 2013. Their clinical and laboratory data were analyzed by BARD score. The results of those who presented score >2 were compared to the rest.

Results

Two hundred ninety-eight patients with hepatic disease were analyzed and among them 70.27 % had score >2. Of the 76 patients with score <1, 1 was diagnosed with liver fibrosis, determining a negative predictive value of 98.68 % for the test (p < 0.05).

Conclusions

The BARD score is still not ideal for the diagnosis of nonalcoholic fatty liver disease, hepatitis, and fibrosis, but it was proved to be effective in the detection of absence of liver fibrosis in a bariatric population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(1):5–10.

    Google Scholar 

  2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease : a global perspective. Semin Liver Dis. 2008;28(4):339–50.

    Article  PubMed  Google Scholar 

  3. de Freitas ACT, Campos ACL, Coelho JCU. The impact of bariatric surgery on nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2008;11(3):267–74.

    Article  PubMed  Google Scholar 

  4. De Almeida SR, Savassi Rocha PR, Dias Sanches M, et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg. 2006;16(3):270–8.

    Article  PubMed  Google Scholar 

  5. Tai C-M, Huang C-K, Hwang J-C, et al. Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. Obes Surg. 2012;22(7):1016–21.

    Article  PubMed  Google Scholar 

  6. Pappachan JM, Viswanath AK. Metabolic surgery: a paradigm shift in type 2 diabetes management. World J Diabetes [Internet]. 2015;6(8):990 .Available from: http://www.wjgnet.com/1948-9358/full/v6/i8/990.htm

    Article  Google Scholar 

  7. Musella M, Apers J, Rheinwalt K, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve gastrectomy at 1 year of follow-up. A European survey. Obes Surg [Internet]. 2015. doi:10.1007/s11695-015-1865-6.

    Google Scholar 

  8. Sinha N, Bockman R. The impact of bariatric surgery on bone metabolism. Curr Opin Orthop. 2007;18(5):505–9.

    Article  Google Scholar 

  9. Raziel A, Sakran N, Facs AS, et al. Current solutions for obesity-related liver disorders : non-alcoholic fatty liver disease and non-alcoholic stetohepatitis. IMAJ. 2015;17:234–8.

    PubMed  Google Scholar 

  10. Ruffillo G, Fassio E, Alvarez E, et al. Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. J Hepatol [Internet]. European Association for the Study of the Liver 2011;54(1):160–3. doi:10.1016/j.jhep.2010.06.028.

    Article  Google Scholar 

  11. Adams LA, Lymp JF, St. Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–21.

    Article  PubMed  Google Scholar 

  12. Mcpherson S, Stewart SF, Henderson E, et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59:1265–9.

    Article  PubMed  Google Scholar 

  13. Cichoż-lach H, Celiński K, Prozorow-król B, et al. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit. 2012;18(12):735–40.

    Google Scholar 

  14. Diabetes SB de. In: de Oliveira JEP, Vencio S, editors. Diretrizes da Sociedade Brasileira de diabetes: 2014–2015. São Paulo: Farmaceutica; 2015 .374 p

    Google Scholar 

  15. Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57(10):1441–7.

    Article  CAS  PubMed  Google Scholar 

  16. Kleiner DE, Blunt EM, van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.

    Article  PubMed  Google Scholar 

  17. Duseja A, Singh SP, Upadhyay R. Non-alcoholic fatty liver disease and metabolic syndrome—position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol Clin Exp Hepatol. Need for the positio2015;5(1):51–68.

    Article  Google Scholar 

  18. Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology [Internet]. Elsevier, Inc2013;145(4):782–9.e4. doi:10.1053/j.gastro.2013.06.057.

    Article  Google Scholar 

  19. Parekh PJ, Majithia R, Diehl DL, et al. Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound. 2015;4(5):85–91 .EUS-LB For Parenchymal Disease

    PubMed  PubMed Central  Google Scholar 

  20. Mahawar KK, Parmar C, Graham Y, et al. Routine liver biopsy during bariatric surgery : an analysis of evidence base. Obes Surg. 2016;26:177–81.

    Article  PubMed  Google Scholar 

  21. Teixeira ARF, Bellodi-privato M, Carvalheira JB, et al. The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory. Obes Surg. 2009;19:1678–84.

    Article  PubMed  Google Scholar 

  22. Shalhub S, Parsee A, Gallagher SF, et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg. 2004;14:54–9.

    Article  PubMed  Google Scholar 

  23. Verna EC. Liver biopsy at the time of bariatric surgery : a benefit for patients and the medical community NALFD diagnosis and staging is an important. Semin Liver Dis. 2014;34:1–6.

    Article  PubMed  Google Scholar 

  24. Dolce CJ, Russo M, Keller JE, et al. Does liver appearance predict histopathologic findings : prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis [Internet]. American Society for Metabolic and Bariatric Surgery2009;5:323–8. doi:10.1016/j.soard.2008.12.008.

    Article  Google Scholar 

  25. Dallal RM, Samuel G, Lord JL, et al. Hemobilia : a rare complication after routine liver biopsy during gastric bypass. Surg Obes Relat Dis. 2007;3:91–3.

    Article  PubMed  Google Scholar 

  26. Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol [Internet]. Elsevier Inc.2009;7(10):1104–12. doi:10.1016/j.cgh.2009.05.033.

    Article  CAS  Google Scholar 

  27. Raszeja-wyszomirska J, Szymanik B, Lawniczak M, et al. Validation of the BARD scoring system in polish patients with nonalcoholic fatty liver disease ( NAFLD ). BMC Gastroenterol. 2010;10:67.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hopital Santa Casa de Misericórdia de Curitiba, Praça Rui Barbosa, 694 - Centro, Curitiba, PR, 80010-030, Brazil

    André Thá Nassif, Sulamita Okayama, Luís Sérgio Nassif, Alcides Branco Filho & José Sampaio Neto

  2. Pontifícia Universidade Católica do Paraná, Curitiba, Brazil

    Thais Ayumi Nagano

Authors
  1. André Thá Nassif
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thais Ayumi Nagano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sulamita Okayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luís Sérgio Nassif
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alcides Branco Filho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. José Sampaio Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to André Thá Nassif.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

This article does not contain any studies with human participants, being done only analysis of patients’ medical records, or animals performed by any of the authors.

For this type of study formal consent is not required.

Informed Consent

Does not apply.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nassif, A.T., Nagano, T.A., Okayama, S. et al. Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease. OBES SURG 27, 394–398 (2017). https://doi.org/10.1007/s11695-016-2284-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-016-2284-z

Keywords

Search

Navigation